Corcept Therapeutics Inc
F:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
F:HTD
|
US |
|
CEL-SCI Corp
F:LSRM
|
US |
|
P
|
Paycom Software Inc
F:0PY
|
US |
|
M
|
McDonald's Corp
XMUN:MDO
|
US |
|
D
|
DoorDash Inc
F:DD2
|
US |
|
C
|
Campbell Soup Co
XMUN:CSC
|
US |
|
G
|
Gen Digital Inc
XMUN:SYM
|
US |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
Taiheiyo Cement Corp
F:TIE
|
JP |
|
A
|
Azimut Holding SpA
F:HDB
|
IT |
|
Sartorius AG
OTC:SOAGY
|
DE |
|
C
|
Canada One Mining Corp
OTC:COMCF
|
CA |
|
R
|
Ramada Investimentos e Industria SA
ELI:RAM
|
PT |
|
W
|
Wells Fargo & Co
XMUN:NWT
|
US |
|
C
|
Cerner Corp
LSE:0R00
|
US |
|
P
|
Progressive Corp
F:PGV
|
US |
|
Indocement Tunggal Prakarsa Tbk PT
OTC:PITPY
|
ID |
|
D
|
DigitalOcean Holdings Inc
XMUN:0SU
|
US |
|
Rolls-Royce Holdings PLC
LSE:RR
|
UK |
|
S
|
Supalai PCL
SET:SPALI
|
TH |
|
I
|
Ipsen SA
OTC:IPSEF
|
FR |
|
E
|
Emira Property Fund
JSE:EMI
|
ZA |
|
E
|
Energy Recovery Inc
F:5E2
|
US |
Wall St Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for HTD is 63.69 EUR with a low forecast of 35.83 EUR and a high forecast of 100.57 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
63.69
EUR
According to Wall Street analysts, the average 1-year price target for HTD is 63.69 EUR with a low forecast of 35.83 EUR and a high forecast of 100.57 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
65%
The compound annual growth rate for Operating Income over the next 8 years is 65%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
46%
The compound annual growth rate for Net Income over the next 8 years is 46%.
